Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data - Sadda, Srinivas R.; Campbell, Joanna; Dugel, Pravin U.; Holekamp, Nancy M.; Kiss, Szilárd; Loewenstein, Anat; Augustin, Albert J.; Shih, Vanessa; Xu, Xiaoshu; Wykoff, Charles C.; Whitcup, Scott M. (Eye (London), 2020)
Keywords: 59; 692/698/1688/512/2613; 692/699/3161/3175; Acuity; Angiogenesis Inhibitors - therapeutic use; Diabetes; Diabetes Mellitus; Diabetic retinopathy; Diabetic Retinopathy - drug therapy; Edema; Eye; Humans; Immunotherapy; Intravitreal Injections; Laboratory Medicine; Macular Edema - drug therapy; Medicine; Medicine & Public Health; Monoclonal antibodies; Ophthalmology; Pharmaceutical Sciences/Technology; Ranibizumab - therapeutic use; Retina; Retinopathy; Surgery; Surgical Oncology; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A - therapeutic use; Visual Acuity